SGO Talent Show
View this special event to enjoy the many talents of SGO Annual Meeting attendees! Solo and group performances perform special instrumental arrangements, musical numbers, and there may even be a few dance moves...! Join our hosts Dr. Kenneth Kim and Dr. Taylor Turner for this special event.
Category
  • SGO Meetings
Format
  • On-Demand
Credits
PARP Inhibitors: A Practical Approach to Selection and Management
A history of PARP inhibitor use and trials and guidance to understand the process for PARP inhibitor selection
Category
  • SGO Meetings
Format
  • On-Demand
Credits
Catching Up to Speed on the Role of Nutritional Supplements
This session describes the rationale for patients to use or avoid certain nutritional supplements while on chemotherapy versus during recovery from treatment for gynecologic cancers.
Category
  • SGO Meetings
  • Pharmacology
Format
  • On-Demand
Credits
2020 Annual Meeting Webinar Series
View all 8 webinars from the SGO 2020 Annual Meeting on Women's Cancer, including discussion of novel treatments/trials for uterine, cervical, and ovarian cancers. CE credit is not available for this content. 
Category
  • SGO Meetings
  • Uterus
  • Cervix
  • Ovary
  • Genetics
  • Pharmacology
Format
  • On-Demand
Credits
Turnover Talk: Current Treatment Decisions for Front Line Ovarian Cancer
Discussion of maintenance therapy with PARPi, or bevacizumab, and improvement in progression free survival after front line treatment for advanced high grade epithelial ovarian cancer
Category
  • Turnover Talks
  • Ovary
  • PARPi
Format
Credits
Turnover Talk: Evaluation and Management Coding for 2021
Discussion of 2021 changes to E&M coding for outpatient visits for billing by time and medical complexity.
Category
  • Turnover Talks
  • Coding
Format
  • On-Demand
Credits
Turnover Talk: Immunotherapy Toxicity
Review of immunotherapy toxicity including timeline and symptoms of endocrinopathies, nephritis, hepatitis, colitis, pneumonitis; treatment for IRAEs; rechallenging patients after resolution of IRAEs.
Category
  • Turnover Talks
  • Immunotherapy
Format
  • On-Demand
Credits
Turnover Talk: Molecular Testing and Patient Selection in Ovarian Cancer
A brief discussion of homologous recombination deficiency, loss of heterozygosity, and molecular markers in ovarian cancer, and how this can guide therapy.
Category
  • Turnover Talks
  • Ovary
  • Genetics
  • Targeted Therapy
Format
  • On-Demand
Credits
Turnover Talk: Novel Discoveries in Endometrial Cancer: Are we finally making progress?
Novel treatments in advanced or recurrent endometrial cancer including targeted therapies and immunotherapies.
Category
  • Turnover Talks
  • Endometrium
  • Pharmacology
  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy
Format
  • On-Demand
Credits
Turnover Talk: RRSO in Mutation Carriers
Short discussion of genetic mutation carriers and recommendations for risk reducing salpingo-oophorectomy.
Category
  • Turnover Talks
  • Ovary
  • Genetics
Format
  • On-Demand
Credits

Pages